Pinetree Therapeutics

Pinetree Therapeutics is focused on developing transformative therapies through targeted protein degradation, particularly in the field of oncology

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Pinetree Therapeutics is focused on developing transformative therapies through targeted protein degradation, particularly in the field of oncology.

02Backed By1 investor

03Recent Activity

FROM DSC Investment

Portfolio company Pinetree Therapeutics transferred EGFR degrader (non-small cell lung cancer treatment) to AstraZeneca in a $500M deal.

MILESTONE·asiae.co.kr

JAN 2024

04Similar Companies

CT

A

AT

ET

LB

05Startup DNA

6

signals

Sectors
Business Model
Technology